97 related articles for article (PubMed ID: 24238821)
41. Familial cerebral cavernomas due to a KRIT1 mutation presenting with epilepsy.
Rajakulendran S; Andole S; Kennedy A
BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699465
[TBL] [Abstract][Full Text] [Related]
42. [Identification of a novel inheritable CCM1 gene mutation of 671del AT in a Chinese family with cerebral cavernous malformation].
Mao Y; Zhao Y; Zhou LF; Huang CX; Shou XF; Gong JL
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1572-5. PubMed ID: 14642111
[TBL] [Abstract][Full Text] [Related]
43. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia.
Cau M; Loi M; Melis M; Congiu R; Loi A; Meloni C; Serrenti M; Addis M; Melis MA
Eur J Med Genet; 2009; 52(5):344-8. PubMed ID: 19454328
[TBL] [Abstract][Full Text] [Related]
44. Familial multiple cavernomatosis: description of a new mutation.
Simón Gozalbo A; Beneyto M; Rodríguez-Luna D; Vilar Ventura RM; Belenguer Benavides A; Geffner Sclarsky D
Neurologia; 2011 Apr; 26(3):184-6. PubMed ID: 21163227
[No Abstract] [Full Text] [Related]
45. Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult.
Denier C; Gasc JM; Chapon F; Domenga V; Lescoat C; Joutel A; Tournier-Lasserve E
Mech Dev; 2002 Sep; 117(1-2):363-7. PubMed ID: 12204286
[TBL] [Abstract][Full Text] [Related]
46. Variable expression of cerebral cavernous malformations in carriers of a premature termination codon in exon 17 of the Krit1 gene.
Lucas M; Costa AF; García-Moreno JM; Solano F; Gamero MA; Izquierdo G
BMC Neurol; 2003 Jul; 3():5. PubMed ID: 12877753
[TBL] [Abstract][Full Text] [Related]
47. Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.
Haghighi A; Fathi D; Shahbazi M; Motahari MM; Friedman B
J Neurol Sci; 2013 Nov; 334(1-2):97-101. PubMed ID: 24007869
[TBL] [Abstract][Full Text] [Related]
48. Cerebral cavernous malformation: new molecular and clinical insights.
Revencu N; Vikkula M
J Med Genet; 2006 Sep; 43(9):716-21. PubMed ID: 16571644
[TBL] [Abstract][Full Text] [Related]
49. The cerebral cavernous malformations proteins.
Li X; Fisher OS; Boggon TJ
Oncotarget; 2015 Oct; 6(32):32279-80. PubMed ID: 26356566
[No Abstract] [Full Text] [Related]
50. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
51. Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations.
Lucas M; Costa AF; Montori M; Solano F; Zayas MD; Izquierdo G
Ann Neurol; 2001 Apr; 49(4):529-32. PubMed ID: 11310633
[TBL] [Abstract][Full Text] [Related]
52. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
[TBL] [Abstract][Full Text] [Related]
53. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
54. Cerebral cavernous malformations and unilateral moyamoya in a patient with a new mutation in the KRIT-1 /CCM1 gene.
Melis M; Cau M; Corraine S; Secci S; Addis M; Melis M
Cerebrovasc Dis; 2014; 38(4):311-2. PubMed ID: 25413039
[No Abstract] [Full Text] [Related]
55. Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.
Chan AC; Li DY; Berg MJ; Whitehead KJ
FEBS J; 2010 Mar; 277(5):1076-83. PubMed ID: 20096037
[TBL] [Abstract][Full Text] [Related]
56. Novel CCM1 mutation in a patient with paraparesis and thoracic cord cavernous malformation.
Waters MF; Shields DC; Martin NA; Baloh RW; Jen JC
Neurology; 2005 Sep; 65(6):966-7. PubMed ID: 16186553
[No Abstract] [Full Text] [Related]
57. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
[TBL] [Abstract][Full Text] [Related]
58. Increased number of white matter lesions in patients with familial cerebral cavernous malformations.
Golden MJ; Morrison LA; Kim H; Hart BL
AJNR Am J Neuroradiol; 2015 May; 36(5):899-903. PubMed ID: 25556204
[TBL] [Abstract][Full Text] [Related]
59. Features of a Chinese family with cerebral cavernous malformation induced by a novel CCM1 gene mutation.
Wang X; Liu XW; Lee N; Liu QJ; Li WN; Han T; Wei KK; Qiao S; Chi ZF
Chin Med J (Engl); 2013; 126(18):3427-32. PubMed ID: 24034083
[TBL] [Abstract][Full Text] [Related]
60. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
